Retatrutide is a new medication in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in investigations. By activating these receptors, Retatrutide suppresses appetite, {promotesinsulin secretion, and ultimately results in significant slimming. While research is aod 9604 peptide